TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms December 15, 1978
TCL Archive GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds April 21, 1989
TCL Archive In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology January 3, 2014
